EP1991049A2 - Procédé d'incubation et d'éclosion d'oeufs - Google Patents
Procédé d'incubation et d'éclosion d'oeufsInfo
- Publication number
- EP1991049A2 EP1991049A2 EP07712286A EP07712286A EP1991049A2 EP 1991049 A2 EP1991049 A2 EP 1991049A2 EP 07712286 A EP07712286 A EP 07712286A EP 07712286 A EP07712286 A EP 07712286A EP 1991049 A2 EP1991049 A2 EP 1991049A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- eggs
- incubation
- egg
- isolator
- hatching
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 235000013601 eggs Nutrition 0.000 title claims abstract description 187
- 238000011534 incubation Methods 0.000 title claims abstract description 70
- 238000000034 method Methods 0.000 title claims abstract description 52
- 230000012447 hatching Effects 0.000 title claims abstract description 49
- 230000002028 premature Effects 0.000 claims abstract description 46
- 230000004580 weight loss Effects 0.000 claims description 27
- 241000271566 Aves Species 0.000 claims description 25
- 238000009423 ventilation Methods 0.000 claims description 19
- 238000003860 storage Methods 0.000 claims description 18
- 241000287828 Gallus gallus Species 0.000 claims description 12
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 11
- 235000005911 diet Nutrition 0.000 claims description 11
- 229910052760 oxygen Inorganic materials 0.000 claims description 11
- 239000001301 oxygen Substances 0.000 claims description 11
- 230000037213 diet Effects 0.000 claims description 10
- 230000000384 rearing effect Effects 0.000 claims description 10
- 238000011533 pre-incubation Methods 0.000 claims description 9
- 238000011109 contamination Methods 0.000 claims description 7
- 230000003247 decreasing effect Effects 0.000 claims description 7
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 239000011782 vitamin Substances 0.000 claims description 4
- 229940088594 vitamin Drugs 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 4
- 239000004599 antimicrobial Substances 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 235000015872 dietary supplement Nutrition 0.000 claims 1
- 239000013589 supplement Substances 0.000 claims 1
- 210000003555 cloaca Anatomy 0.000 abstract description 7
- 238000012546 transfer Methods 0.000 abstract description 7
- 235000013330 chicken meat Nutrition 0.000 description 11
- 230000035899 viability Effects 0.000 description 11
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 10
- 241000894007 species Species 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 210000001161 mammalian embryo Anatomy 0.000 description 9
- 239000003242 anti bacterial agent Substances 0.000 description 7
- 229940088710 antibiotic agent Drugs 0.000 description 7
- 238000001356 surgical procedure Methods 0.000 description 7
- 102000002322 Egg Proteins Human genes 0.000 description 6
- 108010000912 Egg Proteins Proteins 0.000 description 6
- 206010015548 Euthanasia Diseases 0.000 description 6
- 230000036512 infertility Effects 0.000 description 6
- 206010002091 Anaesthesia Diseases 0.000 description 5
- 238000001949 anaesthesia Methods 0.000 description 5
- 230000037005 anaesthesia Effects 0.000 description 5
- 229910002092 carbon dioxide Inorganic materials 0.000 description 5
- 239000001569 carbon dioxide Substances 0.000 description 5
- 210000003278 egg shell Anatomy 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 210000003101 oviduct Anatomy 0.000 description 5
- 210000004291 uterus Anatomy 0.000 description 5
- 210000002257 embryonic structure Anatomy 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 210000004681 ovum Anatomy 0.000 description 3
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 239000003443 antiviral agent Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000002350 laparotomy Methods 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 210000005000 reproductive tract Anatomy 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- XQMVBICWFFHDNN-UHFFFAOYSA-N 5-amino-4-chloro-2-phenylpyridazin-3-one;(2-ethoxy-3,3-dimethyl-2h-1-benzofuran-5-yl) methanesulfonate Chemical compound O=C1C(Cl)=C(N)C=NN1C1=CC=CC=C1.C1=C(OS(C)(=O)=O)C=C2C(C)(C)C(OCC)OC2=C1 XQMVBICWFFHDNN-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000272496 Galliformes Species 0.000 description 1
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 102000029797 Prion Human genes 0.000 description 1
- 108091000054 Prion Proteins 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 241001148470 aerobic bacillus Species 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000002141 anti-parasite Effects 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 229940125687 antiparasitic agent Drugs 0.000 description 1
- 229940121357 antivirals Drugs 0.000 description 1
- 210000004666 bacterial spore Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 239000006047 digesta Substances 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000027632 eggshell formation Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000007045 gastrulation Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 229960002725 isoflurane Drugs 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000017448 oviposition Effects 0.000 description 1
- 238000002559 palpation Methods 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Definitions
- This invention is directed to a method for the incubation and hatching of premature eggs, in particular premature eggs removed in their shell from a bird prior to transfer of the premature egg to the cloaca of a bird.
- European Patent application no. 01650109 is directed to a method for rearing a bird of germ-free status comprising housing a parent bird, removing a premature egg in its shell from the parent bird prior to transfer of the premature egg to the cloaca and incubating the premature egg in its shell and hatching the premature egg to produce a laying bird.
- Ventilation, temperature control and humidity are very important during the incubation and hatching process.
- the eggshell in particular its pores and cuticle, modulate respiratory gas exchange and hydration of the developing embryo.
- the eggshell is a breathable membrane and whilst the embryo is developing the eggshell allows carbon dioxide and water to escape from the egg and oxygen to enter the egg. As the embryo grows, it requires an increased supply of oxygen. Furthermore, care must be taken to maintain the appropriate humidity levels during the hatching period.
- the conditions required for successful incubation and hatching of a normal, naturally laid egg are well known. These conditions vary between species. For example, for domestic fowl such as chickens, the entire process takes from 20 to 22 days, generally 21 days, with incubation conditions applying from Day 0 to Day 18 and hatching conditions applying from Day 18 to 21. During incubation eggs should be positioned so that the domed end, which contains the air cell, is uppermost. Typical incubator conditions are air temperature of 37.5°C, relative humidity (RH) of 50%, and regular turning (rocking) of the eggs so that the longitudinal axis of the eggs is slowly rotated through approximately 80° (40° each side of vertical) once every 45 to 180 minutes.
- RH relative humidity
- the embryos typically move into the hatching position within the egg.
- the eggs should no longer be turned at this stage.
- European Patent no. 0 295 964 describes an in-vitro avian embryo culture technique.
- this specification is directed to the incubation of an embryo in a closed container after the embryo has been removed from its shell.
- the container used is preferably part of an egg shell which has been chosen from the same species as is being cultured or, in the terms of the present invention, from a similar hen.
- European Patent no. 0 511 431 discloses an in-vitro culture method for a fertilised ovum of a hen in which an embryo which has just been fertilised is taken from an upper portion of the magnum of the oviduct of a hen within an hour or so after oviposition and then subsequently cultured. Both of these specifications merely disclose the artificial culturing of eggs which have been removed without their shell.
- the present invention is directed to special techniques for the incubation and hatching of surgically-derived premature eggs in their shell, in particular those derived from the method of European Patent application no. 01650109. These techniques give improved results in terms of yield of surgically-derived eggs when compared to conventional egg incubation and hatching techniques.
- a method for incubating and hatching of a premature egg in its shell in a sterile environment comprising the steps of optionaliy cooling and pre-incubation storage of the egg; placing the premature egg in an incubation isolator adapted to provide variable rocking of the eggs; monitoring ventilation and weight loss of the eggs; during the incubation phase decreasing the relative humidity (RH) in the isolator to a level of from approximately 15% to 40%; during the hatching phase increasing the relative humidity to a level of from approximately 60 to 75% and stopping the rocking of the eggs; and maintaining the eggs in the isolator until hatching.
- RH relative humidity
- the desired relative humidity in the first 18 days of the incubation phase is much lower than required for normal eggs. If this low relative humidity of 15- 40% was used for hatching normal/conventional eggs (i.e. eggs permitted to mature fully in the reproductive tract and laid naturally through the cloaca) it would give very low hatchability rates( ⁇ 40%) whereas for premature eggs, this low relative humidity is the optimal RH range. Thus, using such low relative humidity levels in the incubation phase goes against the conventional teachings in this field.
- a method for incubating and hatching surgically-derived premature eggs in their shell in a sterile environment comprising the following steps: a. Pre-incubation storage of the surgically-derived premature egg; b. Placing the eggs in an incubation isolator adapted to provide variable rocking of the eggs; c. Controlling the ventilation in the isolator; d. Weighing the eggs to monitor weight loss; e. During the incubation phase decreasing the relative humidity to approximately 15% to 40% and altering the temperature in the incubation isolator to obtain a target weight loss during the incubation phase; f.
- the germ-free status of the surgically-derived egg is maintained throughout the method.
- the present invention is directed to incubation and hatching methods for a surgicaily- derived premature egg from optional pre-incubation storage through to incubation and hatching of a viable bird.
- Surgically-derived eggs are premature. In some cases their development, for example gastrulation, may be delayed. Furthermore, it is possible that premature eggs may lack certain features of a full-term naturally laid egg, for example there may be reduced cuticle on the shell and pore formation in the shell may be impaired. It has been found that some surgically-derived eggs, due to premature egg shell formation and effects of surgical anaesthesia, euthanasia methods and timing, may not adequately loose moisture and corresponding body weight which are essential for correct embryo development and chick viability. Therefore, standard hatchery practices for normal laid eggs are not be appropriate to achieve optimum viability of the premature surgically-derived eggs.
- a method for incubating and hatching surgically-derived premature eggs in their shell comprising the following steps: a. Pre-incubation storage of the surgically-derived premature egg; b. Placing the eggs in an incubation isolator adapted to provide variable rocking of the eggs; c. Controlling the ventilation in the isolator; d. Weighing the eggs to monitor weight loss; e. During the incubation phase decreasing the relative humidity to approximately 15% to 40% and altering the temperature in the incubation isolator to obtain a target weight loss during the incubation phase; f.
- the surgically-derived premature egg in its shell is germ-free and the method of the invention is carried out in a sterile atmosphere to ensure germ-free conditions during hatching and incubation.
- the ventilation within the incubator is controlled. Ventilation using a combination of HEPA filtered air and sterile air supplemented with sterile oxygen when appropriate may be used.
- the isolator is provided with facilities to weigh the eggs. This enables direct monitoring of egg weight loss.
- a target weight loss from the start of incubation to prior to the hatching period for an individual egg is from approximately 10 to 15% of the initial egg weight.
- the isolator may be provided with one or more incubators, such that each incubator may simultaneously provide different conditions, specifically relative humidity levels, necessary to optimise weight loss and viability for individual eggs. Separate incubators are used in the situation where wide variations in egg weight loss are anticipated.
- the incubation period is defined as the time period from Day 0 to Day 18 in the incubator. Rocking of the eggs in this time period is essential. Day 0 corresponds to the first day the egg is placed in an incubator. The hatching period is defined as the time period from Day 19 to Day 21. Rocking of the eggs is not required during this time period.
- Relative humidity at normal levels during incubation and hatching is understood to be from approximately 50% to 70%.
- the present method recognises the need to alter conventional incubation and hatchery practices to levels that would not be contemplated in this field.
- the unique characteristics of surgically derived eggs provides specific circumstances where conventional teachings in this field do not achieve the desired hatchability/viabiiity rates.
- relative humidity levels are lowered to from 15 to 35%, preferably, from 25 to 35% during the incubation phase. Additionally, the incubation phase occurs at a temperature of from 36 to 38°C.
- relative humidity levels are raised to from 60 to 75%, preferably approximately 65% during the hatching phase.
- the hatching phase may occur at a temperature of from 36 to 37.5 0 C.
- the hatching phase (step (e)) may commence on or around Day 18.
- the method of the invention is carried out in an incubation isolator.
- the incubator may be a conventional incubator used in standard hatchery techniques or it may be an incubator adapted to conform to the sterility requirements for incubating and hatching a germ-free egg i.e. an incubation isolator.
- an incubation isolator Ideally, the incubation method and incubation isolator maintains the sterility and germ-free status of the premature egg.
- the incubation isolator maybe provided with facilities to monitor and control ventilation rate, to dehumidify air and to achieve oxygen-enriched air (21-23% at 760mm Hg).
- a conventional incubation isolator is used which has been modified and enabled to control ventilation is used.
- the method may further comprise the step of adding oxygen to the incubation isolator. Most preferably, oxygen is added when the humidity in the incubator is decreased.
- the surgically derived eggs are removed from a surgical isolator where surgical removal took place and delivered to the incubation isolator within a short time, for example within 30 minutes from surgery. It is advantageous to ensure that eggs are ventilated with air prior to commencement of incubation.
- the incubation method may also include the additional initial step of cooling the eggs after surgical removal from the parent bird. It may also include a pre-incubation storage step where the eggs may then be stored, undisturbed for, at least 24 hours, preferably not more than 72 hours. In general, preincubation storage may be from 0 to 72 hours. Preferable, storage conditions for the premature egg are: HEPA filtered air, temperature between 15 0 C and 23 0 C, relative humidity of 50% to 75% and storage free from vibration or sudden jarring.
- the eggs may be incubated using sterile equipment and specified contamination or germ-free air.
- the method comprises the following steps: For the first 24 hours standard incubation conditions for the species of egg may be used. Thereafter, each egg should be carefully monitored for weight loss, incubation temperature, relative humidity and, if appropriate respiratory gaseous exchange especially carbon dioxide and oxygen concentrations in air.
- the incubation and hatching conditions can be adjusted according to the invention. Ideally, for 55g surgically-derived premature egg a target weight loss of from approximately 0.4g/day is desirable.
- Incubation temperatures of approximately 37.2-37.6 0 C are preferable initially on Day 0 until Day 18 of incubation and then temperatures of approximately 36.5 - 37.5 0 C are desirable until hatching.
- Relative humidity may initially be set at approximately 40% but should be adjusted daily according to ventilation rate and daily egg weight loss until Day 18 when relative humidity should be increased to approximately 65%.
- the surgical procedure for removal of the premature egg from the uterus of the bird includes incision through the skin of the bird and manipulation of the uterus. It is important that the egg is not contaminated with waste material from the gut of the bird and the egg itself is not damaged during the technique.
- the egg may be removed from the bird either in the intact, sealed (e.g. clamped-off) uterus or directly by incision of the uterus. All direct contact between fluid forms of sterilising solutions should be avoided to counteract any risk of impairment of embryo viability. Aseptic techniques are essential.
- the surgical removal comprises:-
- the bird is anesthetized but may alternatively be sacrificed by euthanasia or killing prior to removal of the egg in its shell.
- Female parent birds may be either live or recently killed. Live birds may, as consistent with ethical, legal and animal welfare considerations, be fully conscious, sedated or anaesthetised. Eggs and ova may be either fertilised or unfertilised.
- the removal of the egg is at a time prior and as close as possible to the transfer time when the egg would transfer naturally to the cloaca in the parent bird.
- the surgically removed egg may then be placed in a sterile container and sealed.
- the container should allow the egg to cool and be of suitable design and size to for egg storage.
- a sterile container is one with an approximate volume 10 times that of the egg, with the egg supported and protected by a plastic frame to ensure both stability and ventilation.
- a suitable environment for hatched chicks, rearing birds, laying and reproductively active birds is a rigid walled isolator, with HEPA- filtered air.
- the air is maintained at positive pressure and exchanged at frequent intervals (e.g. 10 times per hour for adult birds, taking into account cubic capacity of the isolator and stocking density).
- the floor area is ideally from 0.2 - 0.4 m 2 per bird. Gloves on entry ports are protected from damage by birds. Air temperature and lighting controlled to provide conditions similar to those for conventional birds of the same species and stage of life-cycle.
- organic micronutrients such as fat or water-soluble vitamins may be added to compensate for losses occurring during sterilization of the diets and from an absence of supply from commensal micro-organisms. Diets sterilised by gamma radiation have reduced concentrations of fat-soluble and water soluble vitamins. Furthermore, gamma irradiated diets have a limited shelf life and should be monitored for fat rancidity.
- a method for rearing and breeding the surgically derived eggs comprising administering antibiotics to the surgically derived premature eggs in ova.
- antibiotics Preferably, orally administered fluroquinolones are administered and, as appropriate, to the specific micro-organisms to be eliminated, other antimicrobial agents.
- the antibiotics eliminate transovarian bacterial and mycoplasmal infections and have a positive effect on viability and sterility of embryos and subsequent chicks.
- Antivirals, pharmaceuticals, small molecules, peptides and monoclonal antibodies may also be used to eliminate or prevent viral infections.
- fertile eggs are used to produce offspring or derived birds, then the eggs may be hatched, reared, maintained and bred in either conventional husbandry systems, germ-free systems or in isolators to control the entry of micro-organisms.
- eggs should preferably be derived aseptically from parent females (unless they are also germ- free) and the iife-cycle should be completed in isolators.
- the life-cycle may be completed outside isolators when germ-free eggs and birds are produced.
- Premature eggs in their shell were obtained from a parent bird according to the techniques of European Patent application no. 01650109.
- the premature eggs were cooled after surgical removal from the parent bird. They were then stored, undisturbed for, at least 24 hours but not more than 72 hours. Storage conditions were HEPA filtered air, a temperature between 15 and 23 0 C, relative humidity of 50 to 75% and the eggs were stored free from vibration or sudden jarring.
- the eggs were incubated using sterile equipment and specified contamination free air.
- the humidity of the isolator was decreased from 40% on Day 1 to 20 to 25% to increase moisture loss through the egg shell. This encouraged weight loss of the premature egg.
- the humidity was kept at this level up till Day 13 and was then increased to 40% from Days 14 to 18 to obtain 13% weight loss overall from Day 0 to Day 18. After Day 18 the humidity was increased to a normal hatching level of 65%.
- a suitable environment for hatched chicks, rearing birds, laying and reproductively active birds is a rigid wailed isolator, with HEPA-filtered air. The air is maintained at positive pressure and exchanged at frequent intervals (e.g.
- antibiotics e.g. orally administered fluroquinolones
- micronutrient-supplemented diets including, vitamins A, C, E and K, B vitamin complex
- the eggs were weighed and then 40 of the eggs were randomly allocated to one of four small rocking incubators. Two incubators were maintained at a RH of between approx 16 and 29% (nominated 25% RH) and two incubators were maintained at a RH of approx 43 and 54% ⁇ nominated 50% RH). Eggs were held air cell uppermost and were weighted individually on days 0, day 7 and 18 of the incubation. On day 18, all incubators where adjusted to provide a RH of approx 55-71%. Numbers of eggs that pipped and of live viable chicks were recorded.
- Viable chickens were hatched successfully from the artificially derived premature eggs. No anaerobic or aerobic bacteria were isolated from the chickens sampled.
- Infectious organisms that may be controHed by the invention include organisms that can be pathogenic or non-pathogenic to the relevant species. These include avian species (typically chickens, fowls and turkeys), humans and other mammals (typically dogs, cats, horses, cattle, pigs, sheep, goats, rats and mice).
- micro-organisms include parasites, bacteria (including anaerobic and aerobic species, commensal species and species associated with the gut), mycoplasma, viruses (including retroviruses), prions, fungi, yeasts, moulds and DNA and RNA fragments.
- the aseptic derivation of eggs and, if appropriate hatching, rearing, maintenance and breeding of birds may be used in combination with another method of controlling microbial contamination.
- Such methods include disinfectants, antimicrobials, antibiotics, antiviral agents, antiparasitics, immunomodulators and vaccines.
Landscapes
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
Abstract
L'invention concerne un procédé d'incubation et d'éclosion d'oeufs prématurés, en particulier, des oeufs prématurés obtenus par chirurgie prélevés sur un oiseau avant leur passage dans le cloaque de cet oiseau.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07712286A EP1991049A2 (fr) | 2006-02-23 | 2007-02-22 | Procédé d'incubation et d'éclosion d'oeufs |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2006060242 | 2006-02-23 | ||
| PCT/EP2007/051736 WO2007096417A2 (fr) | 2006-02-23 | 2007-02-22 | Procédé d'incubation et d'éclosion d'oeufs |
| EP07712286A EP1991049A2 (fr) | 2006-02-23 | 2007-02-22 | Procédé d'incubation et d'éclosion d'oeufs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1991049A2 true EP1991049A2 (fr) | 2008-11-19 |
Family
ID=39862897
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP07712286A Withdrawn EP1991049A2 (fr) | 2006-02-23 | 2007-02-22 | Procédé d'incubation et d'éclosion d'oeufs |
Country Status (1)
| Country | Link |
|---|---|
| EP (1) | EP1991049A2 (fr) |
-
2007
- 2007-02-22 EP EP07712286A patent/EP1991049A2/fr not_active Withdrawn
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2007096417A3 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8082879B2 (en) | Method for incubation and hatching of eggs | |
| Tahara et al. | A novel shell-less culture system for chick embryos using a plastic film as culture vessels | |
| Barnett et al. | Hatchability and early chick growth potential of broiler breeder eggs with hairline cracks | |
| RU2336885C1 (ru) | Способ выводимости гусиных яиц | |
| RU2436296C2 (ru) | Улучшенные способы получения птичьих яиц и птицы, свободных от специфических микроорганизмов | |
| NZ570338A (en) | A surgical isolator | |
| ES2295126T3 (es) | Un metodo para producir huevos de ave y aves con estado libre de contaminacion especifica. | |
| CN109496971B (zh) | 一种斑嘴环企鹅的人工孵化方法 | |
| EP1991049A2 (fr) | Procédé d'incubation et d'éclosion d'oeufs | |
| NZ570336A (en) | Method for incubation and hatching of surgically-derived premature eggs | |
| HK1132626A (en) | Method for incubation and hatching of eggs | |
| US7117814B2 (en) | Method of producing avian eggs and birds of germ-free status | |
| RU2407482C2 (ru) | Хирургический изолятор | |
| HK1132428A (en) | Improved methods of producing avian eggs and birds of specified germ-free status | |
| CN121286405A (zh) | 一种朱鹮的人工繁育方法 | |
| CN112755177A (zh) | 一种含有鸡胚egf的口服液及制备方法和应用 | |
| AU2013231038A1 (en) | Improved methods of producing avian eggs and birds of specified germ-free status | |
| HK1131876A (en) | A surgical isolator |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20080923 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: OVAGEN INTERNATIONAL LIMITED |
|
| 17Q | First examination report despatched |
Effective date: 20110623 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20120104 |